Projected Income Statement: Daicel Corporation

Forecast Balance Sheet: Daicel Corporation

Fiscal Period: March 2022 2023 2024 2025 2026 2027 2028 2029
Net Debt 1 189,974 223,992 226,607 215,777 235,440 246,960 262,201 267,552
Change - 17.91% 1.17% -4.78% 9.11% 4.89% 6.17% 2.04%
Announcement Date 5/11/22 5/11/23 5/9/24 5/13/25 5/12/26 - - -
1JPY in Million
Estimates

Cash Flow Forecast: Daicel Corporation

Fiscal Period: March 2022 2023 2024 2025 2026 2027 2028 2029
CAPEX 1 40,840 56,308 77,458 69,461 72,828 65,540 70,540 73,560
Change - 37.87% 37.56% -10.32% 4.85% -10.01% 7.63% 4.28%
Free Cash Flow (FCF) 1 -3,535 -29,461 -729 23,945 20,136 25,636 29,350 26,736
Change - -733.41% 97.53% 3,384.64% -15.91% 27.31% 14.49% -8.91%
Announcement Date 5/11/22 5/11/23 5/9/24 5/13/25 5/12/26 - - -
1JPY in Million
Estimates

Forecast Financial Ratios: Daicel Corporation

Fiscal Period: March 2022 2023 2024 2025 2026 2027 2028 2029

Profitability

        
EBITDA Margin (%) 16.86% 14.7% 17.21% 17.46% 14.74% 14.98% 15.34% 16.35%
EBIT Margin (%) 10.83% 8.83% 11.18% 10.4% 7.26% 7.17% 7.6% 8.39%
EBT Margin (%) 9.89% 10.22% 13.62% 11.17% 4.51% 7.78% 8.41% 8.97%
Net margin (%) 6.68% 7.56% 10.01% 8.44% 1.76% 5.32% 5.72% 6.37%
FCF margin (%) -0.76% -5.48% -0.13% 4.08% 3.47% 4.2% 4.65% 4.02%
FCF / Net Income (%) -11.31% -72.42% -1.31% 48.39% 197.8% 79.06% 81.27% 63.06%

Profitability

        
ROA 8.56% 7.11% 8.52% 7.54% 5.48% 6.2% 7.1% 7.71%
ROE 12.3% 14.3% 17.1% 13.8% 2.8% 10.2% 10.12% 11.23%

Financial Health

        
Leverage (Debt/EBITDA) 2.41x 2.83x 2.36x 2.11x 2.76x 2.7x 2.71x 2.46x
Debt / Free cash flow -53.74x -7.6x -310.85x 9.01x 11.69x 9.63x 8.93x 10.01x

Capital Intensity

        
CAPEX / Current Assets (%) 8.73% 10.47% 13.88% 11.84% 12.56% 10.74% 11.17% 11.06%
CAPEX / EBITDA (%) 51.77% 71.2% 80.65% 67.83% 85.27% 71.73% 72.81% 67.65%
CAPEX / FCF (%) -1,155.3% -191.13% -10,625.24% 290.09% 361.68% 255.66% 240.34% 275.13%

Items per share

        
Cash flow per share 1 195.7 246.4 316.6 333.1 203.6 227.2 319.6 -
Change - 25.91% 28.47% 5.21% -38.86% 11.58% 40.67% -
Dividend per Share 1 34 38 50 60 60 69.5 75.75 81.57
Change - 11.76% 31.58% 20% 0% 15.83% 8.99% 7.69%
Book Value Per Share 1 919.9 1,034 1,301 1,358 1,392 1,478 1,539 1,643
Change - 12.35% 25.9% 4.35% 2.55% 6.14% 4.14% 6.75%
EPS 1 104.1 138.9 197.6 181.4 38.75 128.1 144.7 173.6
Change - 33.35% 42.26% -8.16% -78.64% 230.54% 12.95% 19.96%
Nbr of stocks (in thousands) 295,709 285,636 275,817 265,132 256,990 255,393 255,393 255,393
Announcement Date 5/11/22 5/11/23 5/9/24 5/13/25 5/12/26 - - -
1JPY
Estimates
2027 *2028 *
P/E 11.4x 10.1x
PBR 0.99x 0.95x
EV / Sales 1.01x 1x
Yield 4.77% 5.2%

EPS & Dividend



Y-o-Y evolution of P/E

 

Year-on-year evolution of the Yield

Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
8
Last Close Price
1,457.50JPY
Average target price
1,483.75JPY
Spread / Average Target
+1.80%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 4202 Stock
  4. Financials Daicel Corporation